Wellington Management Group LLP grew its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 370.5% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,653,957 shares of the financial services provider's stock after purchasing an additional 2,089,935 shares during the quarter. Wellington Management Group LLP owned approximately 0.74% of CME Group worth $704,068,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of the stock. Wayfinding Financial LLC bought a new stake in CME Group during the first quarter worth $25,000. Cornerstone Planning Group LLC lifted its holdings in CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after acquiring an additional 55 shares during the period. Golden State Wealth Management LLC lifted its holdings in CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after acquiring an additional 98 shares during the period. Alpine Bank Wealth Management bought a new stake in CME Group during the first quarter worth $32,000. Finally, Financial Gravity Asset Management Inc. bought a new stake in CME Group during the first quarter worth $32,000. Institutional investors own 87.75% of the company's stock.
CME Group Price Performance
Shares of NASDAQ CME opened at $270.41 on Tuesday. CME Group Inc. has a fifty-two week low of $206.44 and a fifty-two week high of $290.79. The stock has a fifty day moving average of $275.56 and a 200-day moving average of $267.83. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market cap of $97.45 billion, a PE ratio of 26.18, a price-to-earnings-growth ratio of 4.86 and a beta of 0.44.
CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%. The business had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.68 billion. During the same period in the previous year, the business earned $2.56 earnings per share. The firm's revenue was up 10.4% on a year-over-year basis. Equities research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.
CME Group Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.8%. The ex-dividend date is Tuesday, September 9th. CME Group's payout ratio is presently 48.40%.
Insider Buying and Selling
In related news, Director Charles P. Carey sold 500 shares of the business's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total transaction of $132,675.00. Following the completion of the transaction, the director directly owned 4,900 shares in the company, valued at $1,300,215. The trade was a 9.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William R. Shepard bought 256 shares of CME Group stock in a transaction that occurred on Wednesday, June 25th. The shares were acquired at an average price of $270.53 per share, with a total value of $69,255.68. Following the completion of the transaction, the director owned 258,196 shares of the company's stock, valued at $69,849,763.88. This represents a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.30% of the stock is owned by company insiders.
Analyst Ratings Changes
CME has been the topic of several research reports. Oppenheimer boosted their target price on CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research note on Thursday, July 24th. Piper Sandler boosted their target price on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research note on Tuesday, July 15th. Citigroup boosted their target price on CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research note on Thursday, July 3rd. Barclays set a $298.00 target price on CME Group and gave the company an "equal weight" rating in a research note on Thursday, July 24th. Finally, Keefe, Bruyette & Woods boosted their target price on CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a research note on Thursday, April 24th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat, CME Group currently has an average rating of "Hold" and a consensus target price of $261.93.
Check Out Our Latest Stock Analysis on CME
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access